Patent Applications published on Jun 23, 2022 - page 4

#901 ✅ Patent 11,707,428 granted on 2023-07-25
US20220192971A1
Human necessities

Dye composition comprising a combination of two plant extracts of

#902 ✅ Patent 11,752,093 granted on 2023-09-12
US20220192972A1
Human necessities

Antipsychotic injectable depot composition

#903 ✅ Patent 11,576,855 granted on 2023-02-14
US20220192973A1
Human necessities

Effervescent composition and method of making it

#904 ✅ Patent 12,246,086 granted on 2025-03-11
US20220192974A1
Human necessities

Applications and imaging of shear-thinning biomaterial

#905 ✅ Patent 11,504,323 granted on 2022-11-22
US20220192975A1
Human necessities

Boundary surface charged contact lens for delivery

#906 ✅ Patent 11,382,861 granted on 2022-07-12
US20220192976A1
Human necessities

Nicotine pouch

#907 ✅ Patent 11,964,048 granted on 2024-04-23
US20220192977A1
Human necessities

Sustained release compositions comprising liothyronine

#908
US20220192978A1
Human necessities

Pharmaceutical Inhalation Aerosol and Preparation Method Therefor

#909
US20220192979A1
Human necessities

Liquid Micro-Dosing Product Containing an Effective Amount of Cannabis and Process for Making the Same

#910
US20220192980A1
Human necessities

CATIONIC HYALURONIC ACID COATED SPANLASTICS AND PREPARATION AND APPLICATION THEREOF

#911
US20220192981A1
Human necessities

CATIONIC LIPID EXHIBITING IMPROVED INTRACELLULAR DYNAMICS

#912
US20220192982A1
Human necessities

PRODUCTION OF SALIPRO PARTICLES

#913
US20220192983A1
Human necessities

GRANULAR PRODUCT BASED ON ARGININE

#914
US20220192984A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING OTIC THERAPEUTIC AGENTS AND RELATED METHODS

#915
US20220192985A1
Human necessities

METHOD OF PRODUCTION OF A COMPOSITE OF YEAST-DERIVED BETA GLUCAN PARTICLE WITH INCORPORATED POORLY-WATER-SOLUBLE LOW-MOLECULAR-WEIGHT COMPOUND, PHARMACEUTICAL PREPARATION AND USE THEREOF

#916
US20220192986A1
Human necessities

INJECTABLE, PORE-FORMING HYDROGELS FOR MATERIALS-BASED CELL THERAPIES

#917
US20220192987A1
Human necessities

MICROCAPSULES CONTAINING CURCUMIN, AND METHODS FOR THE PRODUCTION THEREOF

#918
US20220192988A1
Human necessities

METHOD FOR PREPARING STABLE PEPTIDE FORMULATIONS

#919
US20220192989A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY ARRHYTHMIAS

#920
US20220192990A1
Human necessities

TABLETS WITH IMPROVED FRIABILITY

#921 ✅ Patent 11,413,249 granted on 2022-08-16
US20220192991A1
Human necessities

Synthetic progestogens and pharmaceutical compositions comprising the same

#922
US20220192992A1
Human necessities

PROTECTION OF MONOCLONAL ANTIBODY INTEGRITY AGAINST EVAPORATIVE SOLIDIFICATION, COMPRESSION AND PROTEOLYSIS BY DEXTRAN AND CYCLODEXTRIN DERIVATIVES

#923
US20220192993A1
Human necessities

DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF

#924
US20220192994A1
Human necessities

SOFTGEL FILL MATERIAL

#925
US20220192995A1
Human necessities

COATINGS FOR GASTRIC RESIDENCE DOSAGE FORMS

#926
US20220192996A1
Human necessities

CORE-SHELL STRUCTURE, PREPARATION, MEDICINE FOR EXTERNAL APPLICATION, TAPE AGENT AND COSMETIC PRODUCT

#927
US20220192997A1
Human necessities

VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES

#928
US20220192998A1
Human necessities

NEW DELIVERY SYSTEM FOR POLYUNSATURATED FATTY ACIDS

#929
US20220192999A1
Human necessities

USE OF GOLD NANOCLUSTERS IN TREATING HYPERCHOLESTEROLEMIA OR HYPERCHOLESTEROLEMIA-ASSOCIATED DISEASES

#930
US20220193000A1
Human necessities

KETAMINE TRANSDERMAL DELIVERY SYSTEM

#931 ✅ Patent 12,201,732 granted on 2025-01-21
US20220193001A1
Human necessities

Transdermal patches for hangover minimization and/or recocery, and/or sleep improvement

#932
US20220193002A1
Human necessities

PROCESS FOR THE PREPARATION OF BAKUCHIOL COMPOSITION SUBSTANTIALLY FREE OF FURANOCOUMARIN IMPURITIES

#933
US20220193003A1
Human necessities

CANNABINOID COMPOSITIONS AND METHODS OF USE THEREOF FOR IMMUNE MODULATION

#934 ✅ Patent 12,083,078 granted on 2024-09-10
US20220193004A1
Human necessities

Parenteral cannabinoid formulations and uses thereof

#935 ✅ Patent 11,957,728 granted on 2024-04-16
US20220193005A1
Human necessities

Compositions for targeting receptor for advanced glycation end-products (RAGE) in a chronic inflammatory condition

#936
US20220193006A1
Human necessities

COMPOSITIONS FOR EFFECTIVE MANAGEMENT OF FIBROBLAST-LIKE SYNOVIOCYTES MEDIATED RHEUMATOID ARTHRITIS

#937 ✅ Patent 12,053,440 granted on 2024-08-06
US20220193007A1
Human necessities

Inhibition of COVID-19 virus by formulations containing curcumin, harmine, and isovanillin

#938
US20220193008A1
Human necessities

BIOACCESSIBILE COMPOSITIONS OF LIPOPHILIC COMPOUNDS AND PROCESS THEREOF

#939
US20220193009A1
Human necessities

METHODS OF MODULATING TETRABENAZINE METABOLITES PLASMA LEVELS USING BUPROPION

#940
US20220193010A1
Human necessities

METHODS OF USING DIPIVEFRIN

#941 ✅ Patent 11,786,488 granted on 2023-10-17
US20220193011A1
Human necessities

Dosage forms and methods for enantiomerically enriched or pure bupropion

#942 ✅ Patent 11,617,728 granted on 2023-04-04
US20220193012A1
Human necessities

Bupropion as a modulator of drug activity

#943
US20220193013A1
Human necessities

Pharmaceutical Composition for Treatment or Prevention of Multiple Inflammatory Disorders

#944
US20220193014A1
Human necessities

LIPID PHARMACEUTICAL PREPARATION AND APPLICATION THEREOF

#945 ✅ Patent 11,986,446 granted on 2024-05-21
US20220193015A1
Human necessities

Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

#946
US20220193016A1
Human necessities

COMPOSITIONS, METHODS AND USES FOR TARGETING C-TERMINAL BINDING PROTEIN (CtBP) IN TRAUMATIC BRAIN INJURY

#947 ✅ Patent 12,350,244 granted on 2025-07-08
US20220193017A1
Human necessities

NOVEL MEK-INHIBITOR FOR THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS

#948
US20220193018A1
Human necessities

Omega-3 compositions and methods relating thereto

#949
US20220193019A1
Human necessities

TREATMENT OF AL AMYLOIDOSIS WITH MELFLUFEN

#950 ✅ Patent 12,285,401 granted on 2025-04-29
US20220193020A1
Human necessities

Pharmaceutical composition comprising trimebutine or pharmaceutically acceptable salt thereof as an active ingredient for prevention or treatment of cancer

#951
US20220193021A1
Human necessities

COMBINATION THERAPY FOR TREATING INFLUENZA VIRUS INFECTION

#952
US20220193022A1
Human necessities

METHOD OF TREATING CHRONIC KIDNEY DISEASE

#953 ✅ Patent 12,226,391 granted on 2025-02-18
US20220193023A1
Human necessities

Method of treating tumours

#954
US20220193024A1
Human necessities

USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTIFORME AND MEDULLOBLASTOMA

#955
US20220193025A1
Human necessities

USE OF DIANHYDROHEXITOL TO ELIMINATE THE COSMETIC EFFECTS OF ACNE, DANDRUFF AND BAD ODORS

#956 ✅ Patent 11,786,501 granted on 2023-10-17
US20220193026A1
Human necessities

Nitroxyl donors with improved therapeutic index

#957
US20220193027A1
Human necessities

TRACKING SYSTEM FOR CULTIVATED PRODUCTS AND ASSOCIATED METHODS

#958
US20220193028A1
Human necessities

THERAPEUTIC COMBINATIONS, LIQUID PHARMACEUTICAL COMPOSITIONS, KITS FOR THEIR PREPARATION, AND METHODS OF THEIR USE

#959
US20220193029A1
Human necessities

BRYOSTATIN COMPOUNDS FOR ENHANCEMENT OF IMMUNOTHERAPY

#960
US20220193030A1
Human necessities

USE OF GINKGO TERPENE LACTONE IN PREPARING DRUG FOR PREVENTING AND/OR TREATING GUILLAIN-BARRE-STROHL SYNDROME

#961
US20220193031A1
Human necessities

Vaginal Tablet Formulation

#962 ✅ Patent 12,310,942 granted on 2025-05-27
US20220193032A1
Human necessities

Pharmaceutical compositions comprising statins and hyaluronic acid derivatives

#963
US20220193033A1
Human necessities

NEW DELIVERY SYSTEM FOR SPECIFIC WATER-SOLUBLE VITAMINS

#964
US20220193034A1
Human necessities

COMPOUNDS AND METHODS FOR THE TREATMENT OF PARASITIC DISEASES

#965
US20220193035A1
Human necessities

INDOLE COMPOUNDS FOR USE IN NEURORESTORATION

#966 ✅ Patent 11,752,133 granted on 2023-09-12
US20220193036A1
Human necessities

Use of bromophenol-pyrazoline compounds in the treatment of porcine coronavirus diseases

#967
US20220193037A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING AT LEAST ONE AZOLATED LOCAL ANTIFUNGAL SUBSTANCE

#968
US20220193038A1
Human necessities

COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION

#969
US20220193039A1
Human necessities

APPLICATION OF 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES IN ANTIVIRAL THERAPY

#970 ✅ Patent 12,128,032 granted on 2024-10-29
US20220193040A1
Human necessities

Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry

#971
US20220193041A1
Human necessities

NOVEL COMPOUND AND METHOD FOR PREVENTING OR TREATING OF RESPIRATORY DISEASES COMPRISING THE SAME AS AN ACTIVE INGREDIENT

#972
US20220193042A1
Human necessities

NITAZOXANIDE AND THIAZOLIDES FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH OXIDATIVE STRESS

#973
US20220193043A1
Human necessities

Pharmaceutical Combination Formulations Comprising Tizanidine, Resveratrol and Piperine

#974 ✅ Patent 11,819,495 granted on 2023-11-21
US20220193044A1
Human necessities

Compositions and methods for treating severe constipation

#975
US20220193045A1
Human necessities

PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF

#976 ✅ Patent 12,083,103 granted on 2024-09-10
US20220193046A1
Human necessities

Tacrolimus for improved treatment of transplant patients

#977
US20220193047A1
Human necessities

METHODS OF ENHANCING RADIOTHERAPY USING FERROPTOSIS INDUCERS AS RADIOSENSITIZERS

#978 ✅ Patent 12,350,260 granted on 2025-07-08
US20220193048A1
Human necessities

PROTEASE-ACTIVATED RECEPTOR-2 INHIBITORS FOR THE TREATMENT OF SENSORY NEUROPATHY INDUCED BY A MARINE NEUROTOXIC POISONING

#979
US20220193049A1
Human necessities

COMPOSITION COMPRISING CLAY MINERAL COMPLEX FOR PREVENTION, ALLEVIATION, AND TREATMENT OF INFLAMMATORY BOWEL DISEASE, PREPARATION METHOD FOR COMPOSITION, AND METHOD FOR ALLEVIATION AND TREATMENT FOR INFLAMMATORY BOWEL DISEASE

#980
US20220193050A1
Human necessities

ORAL FORMULATION FOR A PD-L1 INHIBITOR

#981 ✅ Patent 11,717,515 granted on 2023-08-08
US20220193051A1
Human necessities

Treatment of migraine

#982
US20220193052A1
Human necessities

LIQUID PHARMACEUTICAL COMPOSITION

#983
US20220193053A1
Human necessities

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

#984
US20220193054A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING FEXOFENADINE, FAMOTIDINE AND MELATONIN

#985
US20220193055A1
Human necessities

METHODS OF TREATING NEUROLOGICAL, METABOLIC, AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED PIOGLITAZONE

#986 ✅ Patent 12,161,635 granted on 2024-12-10
US20220193056A1
Human necessities

Compositions and methods of treating PIK3CA helical domain mutant cancers

#987 ✅ Patent 11,452,721 granted on 2022-09-27
US20220193057A1
Human necessities

Formulations of pimavanserin

#988 ✅ Patent 12,115,154 granted on 2024-10-15
US20220193058A1
Human necessities

Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)

#989 ✅ Patent 12,357,624 granted on 2025-07-15
US20220193059A1
Human necessities

LOW DOSE PRIDOPIDINE FOR PARKINSON'S DISEASE AND OTHER DISEASES ASSOCIATED WITH PARKINSONISM

#990
US20220193060A1
Human necessities

Inhibition of IL-1 Induced Inflammation

#991
US20220193061A1
Human necessities

METHOD OF TREATING A SKIN CONDITION

#992
US20220193062A1
Human necessities

COMBINATION OF ENZASTAURIN AND INHIBITORS OF BTK AND USES THEREOF

#993
US20220193063A1
Human necessities

METABOLITES OF GLP1R AGONISTS

#994
US20220193064A1
Human necessities

MEDICAMENT FOR TREATING CANCER

#995
US20220193065A1
Human necessities

COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

#996
US20220193066A1
Human necessities

QUINOLINE DERIVATIVE USED FOR COMBINATION TREATMENT OF SMALL CELL LUNG CANCER

#997
US20220193067A1
Human necessities

QUINOLINE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR TREATING EWING'S SARCOMA

#998
US20220193068A1
Human necessities

A GRK2 PROTEIN INHIBITOR COMPOUND AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

#999
US20220193069A1
Human necessities

CAMPTOTHECIN PEPTIDE CONJUGATES

#1000
US20220193070A1
Human necessities

METHODS FOR TREATING ABSENCE SEIZURES

#1001
US20220193071A1
Human necessities

METHODS FOR CANCER THERAPY

#1002
US20220193072A1
Human necessities

METHODS OF TREATING BREAST CANCER WITH TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADER

#1003 ✅ Patent 12,053,467 granted on 2024-08-06
US20220193073A1
Human necessities

Method of treating fibrosis

#1004
US20220193074A1
Human necessities

COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING TYROSINE KINASE INHIBITOR RESISTANT EGFR MUTATIONS

#1005
US20220193075A1
Human necessities

THERAPEUTIC DRUG FOR DYSKINESIA

#1006
US20220193076A1
Human necessities

METHODS OF TREATING BREAST CANCER WITH TUCATINIB

#1007
US20220193077A1
Human necessities

METHODS AND COMPOSITIONS COMPRISING A KRASG12C INHIBITOR AND A EGFR-INHIBITOR FOR TREATING SOLID TUMORS

#1008
US20220193078A1
Human necessities

METHODS FOR TREATING OCULAR SURFACE PAIN

#1009
US20220193079A1
Human necessities

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

#1010
US20220193080A1
Human necessities

ALLOSTERIC AGONISTS AND POSITIVE ALLOSTERIC MODULATORS OF GLUCAGON-LIKE PEPTIDE 1 RECEPTOR

#1011
US20220193081A1
Human necessities

LIQUID SILDENAFIL CITRATE COMPOSITIONS

#1012
US20220193082A1
Human necessities

COMBINATION TREATMENT OF SPECIFIC FORMS OF EPILEPSY

#1013
US20220193083A1
Human necessities

ANTI-VIRAL ACTIVITY OF VPS34 INHIBITORS

#1014
US20220193084A1
Human necessities

INHIBITORS OF EZH2 AND METHODS OF USE THEREOF

#1015
US20220193085A1
Human necessities

METHODS OF THROMBOPROPHYLAXIS

#1016 ✅ Patent 12,161,644 granted on 2024-12-10
US20220193086A1
Human necessities

Combination therapy

#1017
US20220193087A1
Human necessities

COMBINATION THERAPIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS

#1018 ✅ Patent 12,016,866 granted on 2024-06-25
US20220193088A1
Human necessities

Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloids

#1019 ✅ Patent 11,826,372 granted on 2023-11-28
US20220193089A1
Human necessities

Combinations including ABX196 for the treatment of cancer

#1020 ✅ Patent 12,171,769 granted on 2024-12-24
US20220193090A1
Human necessities

Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposure

#1021
US20220193091A1
Human necessities

COMBINED ADMINISTRATION OF DIAZEPAM AND DICLOFENAC FOR THE TREATMENT OF PAIN

#1022
US20220193092A1
Human necessities

PROGESTOGEN FOR USE IN THE TREATMENT OF CYTOKINE RELEASE SYNDROME

#1023 ✅ Patent 11,883,415 granted on 2024-01-30
US20220193093A1
Human necessities

High concentration formulation

#1024 ✅ Patent 11,471,471 granted on 2022-10-18
US20220193094A1
Human necessities

Aqueous oral pharmaceutical suspension compositions

#1025
US20220193095A9
Human necessities

PHARMACEUTICAL COMPOSITIONS

#1026
US20220193096A1
Human necessities

INHIBITORS OF NCCA-ATP CHANNELS FOR THERAPY

#1027
US20220193097A1
Human necessities

USE OF 1-DI-ISOPROPYL-PHOSPHINOYL-ALKANE COMPOUNDS FOR TREATMENT OF OCULAR DISCOMFORT

#1028
US20220193098A1
Human necessities

COMPOSITION FOR USE IN PREVENTION OR REDUCTION OF OXIDATIVE STRESS AND NEURODEGENERATIVE DISEASES

#1029
US20220193099A1
Human necessities

IMMUNOMODULATORY OLIGOSACCHARIDES FOR THE TREATMENT OF PAIN

#1030
US20220193100A1
Human necessities

COMPOSITION CONTAINING GLUCORAPHANIN AND USE THEREOF

#1031
US20220193101A1
Human necessities

Methods for treating and Pharmaceutical compositions

#1032
US20220193102A1
Human necessities

COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

#1033
US20220193103A1
Human necessities

NANO-PUERARIN REGULATES TUMOR MICROENVIRONMENT AND FACILITATES CHEMO- AND IMMUNOTHERAPY IN MURINE TRIPLE NEGATIVE BREAST CANCER MODEL

#1034 ✅ Patent 12,274,710 granted on 2025-04-15
US20220193104A1
Human necessities

Compound for regulating body weight imbalance, composition thereof and application thereof

#1035 ✅ Patent 12,115,180 granted on 2024-10-15
US20220193105A1
Human necessities

PH responsive drug conjugated nanocarriers

#1036 ✅ Patent 11,883,423 granted on 2024-01-30
US20220193106A1
Human necessities

Nucleobase analogue derivatives and their applications

#1037 ✅ Patent 12,303,524 granted on 2025-05-20
US20220193107A1
Human necessities

Compositions comprising S-adenosylmethionine and a gallic acid ester

#1038
US20220193108A1
Human necessities

Immunotherapeutic Nanoparticles And Methods Relating Thereto

#1039
US20220193109A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING RAS-MUTANT CANCERS

#1040 ✅ Patent 12,194,057 granted on 2025-01-14
US20220193110A1
Human necessities

NXTAR-derived oligonucleotides and uses thereof

#1041
US20220193111A1
Human necessities

Method of Treatment

#1042
US20220193112A1
Human necessities

HETERO-STRUCTURED RIBONUCLEIC ACID AND USE THEREOF

#1043
US20220193113A1
Human necessities

NOVEL THERAPEUTIC AGENT FOR GASTROINTESTINAL CANCER AND METHOD FOR SCREENING FOR THE SAME

#1044
US20220193114A1
Human necessities

NEUROGENESIS

#1045 ✅ Patent 12,280,071 granted on 2025-04-22
US20220193115A1
Human necessities

Self-assembled nano-fibers as hemostatic agent

#1046 ✅ Patent 12,251,397 granted on 2025-03-18
US20220193116A1
Human necessities

Cross-linked hyaluronic acids and combinations with PRP/BMC

#1047
US20220193117A1
Human necessities

Hyaluronic Acid Nanoparticles Comprising NADPH Oxidases Inhibitors and Uses in Treating Cancer

#1048
US20220193118A1
Human necessities

METHOD FOR SUPPRESSING INTERVERTEBRAL DISC PAIN

#1049
US20220193119A1
Human necessities

ANTISEPTIC SKIN PREP COMPOSITION

#1050
US20220193120A1
Human necessities

MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR MAINTAINING LUNG FUNCTION IN HUMAN LUNG CANCER AND/OR IMPROVING REDUCTION IN LUNG FUNCTION ATTRIBUTED TO HUMAN LUNG CANCER

#1051 ✅ Patent 11,759,477 granted on 2023-09-19
US20220193121A1
Human necessities

Compositions of nitrates and methods of use thereof

#1052 ✅ Patent 12,156,885 granted on 2024-12-03
US20220193122A1
Human necessities

Methods and compositions for treating heart conditions

#1053 ✅ Patent 12,152,089 granted on 2024-11-26
US20220193123A1
Human necessities

LHRH-platinum conjugates for treating reproductive cancers

#1054
US20220193124A1
Human necessities

Therapeutic Agent for Flavivirus Infection

#1055 ✅ Patent 12,324,814 granted on 2025-06-10
US20220193125A1
Human necessities

MANGANESE COMPOSITION FOR ENHANCING IMMUNITY

#1056
US20220193126A1
Human necessities

METHODS OF TREATING IMBALANCE OF PLASMA LIPIDS LEVEL AND FATTY LIVER WITH M2C MACROPHAGES

#1057
US20220193127A1
Human necessities

IMMUNOTHERAPY FOR OPIOID ADDICTION

#1058
US20220193128A1
Human necessities

A COMPOSITION, A KIT AND USE THEREOF

#1059
US20220193129A1
Human necessities

B CELLS FOR IN VIVO DELIVERY OF THERAPEUTIC AGENTS AND DOSAGES THEREOF

#1060 ✅ Patent 11,723,926 granted on 2023-08-15
US20220193130A1
Human necessities

Senescent cell-associated antigen-binding domains, antibodies and chimeric antigen receptors comprising the same, and uses thereof

#1061
US20220193131A1
Human necessities

Methods of Expanding Tumor Infiltrating Lymphocytes Using Engineered Cytokine Receptor Pairs and Uses Thereof

#1062
US20220193132A1
Human necessities

ANTI-EGFRVIII ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THEREOF

#1063 ✅ Patent 11,883,432 granted on 2024-01-30
US20220193133A1
Human necessities

Chimeric antigen receptor system with adaptable receptor specificity

#1064
US20220193134A1
Human necessities

CO-USE OF LENALIDOMIDE WITH CAR-T CELLS

#1065
US20220193135A1
Human necessities

MODIFIED IMMUNE EFFECTOR CELL AND PREPARATION METHOD THEREFOR

#1066
US20220193136A1
Human necessities

BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 AND CD20

#1067
US20220193137A1
Human necessities

MODIFIED IMMUNE RECEPTOR CONSTRUCTS

#1068
US20220193138A1
Human necessities

ENGINEERED NATURAL KILLER CELLS REDIRECTED TOWARD PURINERGIC SIGNALING, CONSTRUCTS THEREOF, AND METHODS FOR USING THE SAME

#1069 ✅ Patent 12,247,061 granted on 2025-03-11
US20220193139A1
Human necessities

Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapy

#1070
US20220193140A1
Human necessities

WASHED PLATELET EXTRACT

#1071
US20220193141A1
Human necessities

COMPOSITIONS COMPRISING STEM CELLS EXPRESSING MESENCHYMAL AND NEURONAL MARKERS AND USES THEREOF TO TREAT NEUROLOGICAL DISEASE

#1072
US20220193142A1
Human necessities

METHOD FOR PREDICTING EFFECTIVENESS OF TREATMENT OF HEMOGLOBINOPATHY

#1073
US20220193143A1
Human necessities

CARTILAGE TISSUE

#1074 ✅ Patent 12,171,787 granted on 2024-12-24
US20220193144A1
Human necessities

Methods and compositions for modulating angiogenesis and vasculogenesis

#1075 ✅ Patent 12,016,888 granted on 2024-06-25
US20220193145A1
Human necessities

Process for obtaining biologically active compositions from emu oil, anti-inflammatory and anti-irritant pharmaceutical composition, and skin regenerative pharmaceutical composition

#1076
US20220193146A1
Human necessities

Composition For Inhibiting Non-Fluorescent Advanced Glycation End Products, And Use Thereof

#1077
US20220193147A1
Human necessities

Anti-aging Composition Containing Akkermansia Muciniphila as Active Ingredient and a Method for Preventing Aging Using Thereof

#1078
US20220193148A1
Human necessities

USE OF NOCARDIA RUBRA CELL WALL SKELETON IN TREATMENT OF THERMAL INJURY

#1079
US20220193149A1
Human necessities

COMPOSITIONS AND METHODS FOR TARGETING TUMOR-ASSOCIATED EXTRACELLULAR MATRIX COMPONENTS TO IMPROVE DRUG DELIVERY

#1080
US20220193150A1
Human necessities

Method and System for Reducing the Likelihood of Developing Depression in an Individual

#1081
US20220193151A1
Human necessities

THERAPEUTIC MICROBIOTA FOR THE TREATMENT AND/OR PREVENTION OF DYSBIOSIS

#1082 ✅ Patent 11,801,273 granted on 2023-10-31
US20220193152A1
Human necessities

Compositions and methods to increase production of isothiocyanates

#1083 ✅ Patent 11,786,565 granted on 2023-10-17
US20220193153A1
Human necessities

Strains of which inhibit

#1084
US20220193154A1
Human necessities

PREOPERATIVE COMPOSITIONS AND METHODS OF PREPARATION THEREOF

#1085
US20220193155A1
Human necessities

MICROBIAL COMPOSITIONS AND METHODS FOR GREATER TOLERABILITY AND PROLONGED SHELF LIFE

#1086
US20220193156A1
Human necessities

PREOPERATIVE COMPOSITIONS AND METHODS OF PREPARATION THEREOF

#1087 ✅ Patent 12,318,417 granted on 2025-06-03
US20220193157A1
Human necessities

compositions and methods for prevention and treatment of microbial infection

#1088 ✅ Patent 11,969,449 granted on 2024-04-30
US20220193158A1
Human necessities

Composition for use in the treatment of major depressive disorder

#1089
US20220193159A1
Human necessities

COMPOSITION, PRODUCTION METHOD FOR PRODUCING THE SAME, AND METHOD OF PREVENTING CAKING

#1090
US20220193160A1
Human necessities

USE OF SPECIFIC PHAGES FOR THE TREATMENT OF NONTUBERCULOSIS MYCOBACTERIA (NTM) INFECTIONS

#1091 ✅ Patent 12,364,723 granted on 2025-07-22
US20220193161A1
Human necessities

LYOPHILIZED VIRUS FORMULATIONS

#1092
US20220193162A1
Human necessities

FUNGAL EXTRACTS AND FLAVOR COMBINATIONS THEREOF

#1093
US20220193163A1
Human necessities

COMPOSITION COMPRISING ACTINIDIA POLYGAMA EXTRACT FOR ALLEVIATING SKIN DAMAGE OR MOISTURIZING SKIN

#1094 ✅ Patent 11,766,466 granted on 2023-09-26
US20220193164A1
Human necessities

Extraction and purification of cannabinoids

#1095
US20220193165A1
Human necessities

Oral Cannabis Substance and Method of Making Such Substance

#1096 ✅ Patent 11,986,504 granted on 2024-05-21
US20220193166A1
Human necessities

Okra as a substitute for cervical mucus

#1097
US20220193167A1
Human necessities

COMBINATION THERAPY FOR TREATMENT OF SKIN DISEASES

#1098 ✅ Patent 11,638,734 granted on 2023-05-02
US20220193168A1
Human necessities

High yield extraction method for and products of plants

#1099
US20220193169A1
Human necessities

ANTI-INFLAMMATORY COMPOSITION

#1100
US20220193170A1
Human necessities

Nutraceutical Reduction Prevention and/or Reversion of Multiple Sclerosis

#1101
US20220193171A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING MIXTURE EXTRACT OF COPTIS RHIZOME AND SCHIZONEPETA TENUIFOLIA AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF INFLAMMATORY BOWEL DISEASE

#1102
US20220193172A1
Human necessities

COMPOSITION FOR USE IN IMPROVING ENDOTHELIAL FUNCTION BY ENHANCING FLOW MEDIATED DILATION

#1103
US20220193173A1
Human necessities

Traditional Chinese Medicine Composition for Loosening Bowel to Relieve Constipation, Preparation Method and Application Thereof

#1104
US20220193174A1
Human necessities

NASAL SPRAY FOR PREVENTING INFLUENZA BASED ON RED PEPPER EXTRACT AND HEPARIN AND PREPARATION METHOD THEREOF

#1105
US20220193175A1
Human necessities

FUNCTIONAL TEA CONTAINING BENEFICIAL INGREDIENTS FOR THE HUMAN BODY

#1106
US20220193176A1
Human necessities

COMPOSITION OF CHINESE MEDICAL HERB FOR INHIBITING COVID-19 VIRUS, USE OF SAME, AND METHOD OF MAKING SAME

#1107
US20220193177A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING DYSBIOSIS OF ORAL MICROBIOME

#1108 ✅ Patent 12,053,500 granted on 2024-08-06
US20220193178A1
Human necessities

Compositions for management of acute nephrotoxicity

#1109
US20220193179A1
Human necessities

USE OF CYCLO(HIS-PRO) (CHP) FOR PREVENTING, ALLEVIATING OR TREATING PERITONEAL FIBROSIS

#1110
US20220193180A1
Human necessities

AGING PROGRESSION SUPPRESSING AGENT, AND FOOD OR BEVERAGE PRODUCT COMPRISING SAME

#1111
US20220193181A1
Human necessities

S-NITROSOGLUTATHIONE (GSNO) AND GSNO REDUCATASE INHIBITORS FOR USE IN THERAPY

#1112 ✅ Patent 12,226,444 granted on 2025-02-18
US20220193182A1
Human necessities

Compositions comprising peptides comprising variant kinesin light chain 1 and cell-penetrating peptides

#1113
US20220193183A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING RENAL FAILURE

#1114 ✅ Patent 11,801,281 granted on 2023-10-31
US20220193184A1
Human necessities

Tissue occluding agent comprising an ieikieikieiki peptide

#1115
US20220193185A1
Human necessities

COMBINATION OF SYNTHETIC PEPTIDES WITH AFFINITY TO THE TGF-ß RECEPTOR AND WITH AFFINITY TO THE IL-10 RECEPTOR, PHARMACEUTICAL COMPOSITION AND THEIR USE AS IMMUNOMODULATORS IN THE TREATMENT OF AUTOIMMUNE, INFLAMMATORY OR ALLERGIC DISEASES

#1116
US20220193186A1
Human necessities

METHOD OF TREATING AND PREVENTING BONE AND JOINT INFECTIONS

#1117 ✅ Patent 11,679,141 granted on 2023-06-20
US20220193187A1
Human necessities

Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof

#1118
US20220193188A1
Human necessities

DIAGNOSIS, PREVENTION, AND/OR TREATMENT OF AUTOIMMUNE DISEASES

#1119
US20220193189A1
Human necessities

USE OF Dvl3-DEP PEPTIDE IN PREPARATION OF MEDICAMENT FOR REPAIRING SERTOLI CELL INJURY IN TESTES

#1120
US20220193190A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING FRATAXIN FUSION PROTEIN AND METHODS OF USE THEREOF

#1121
US20220193191A1
Human necessities

LIPOCALIN MUTEIN FOR TREATMENT OF ASTHMA

#1122
US20220193192A1
Human necessities

METHODS OF TREATING A TRAUMATIC BRAIN INJURY

#1123
US20220193193A1
Human necessities

METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF METABOLIC DISORDERS USING SLIT2

#1124
US20220193194A9
Human necessities

Method of treating cancer with an immune checkpoint inhibitor in combination with another therapeutic agent

#1125
US20220193195A1
Human necessities

LYMPHOTOXIN ALPHA FOR USE IN THERAPY OF MYELOID LEUKEMIA

#1126
US20220193196A1
Human necessities

Methods for Modulating T Cell Activation

#1127
US20220193197A1
Human necessities

SYNERGISTIC TUMOR TREATMENT WITH IL-2 AND INTEGRIN-BINDING-FC FUSION PROTEIN

#1128
US20220193198A1
Human necessities

Interleukin-2 Variants with Modified Biological Activity

#1129
US20220193199A1
Human necessities

IL-15 AND IL-15RALPHA SUSHI DOMAIN BASED MODULOKINES

#1130
US20220193200A1
Human necessities

TANNIC ACID/FE (III) NANOPARTICLES AND METHODS OF DRUG DELIVERY

#1131
US20220193201A1
Human necessities

GLP-1R AGONIST REDUCES RETINAL INFLAMMATION AND NEURON DEATH SECONDARY TO OCULAR HYPERTENSION

#1132
US20220193202A1
Human necessities

PARATHYROID HORMONE DERIVATIVE IN DIMERIC FORM OF PARATHYROID HORMONE FRAGMENT AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF BONE DISEASES COMPRISING SAME

#1133
US20220193203A1
Human necessities

METHODS OF IMPROVING SPINAL FUSION WITH ABALOPARATIDE

#1134
US20220193204A1
Human necessities

USES OF A2 DOMAIN OF VON WILLEBRAND FACTOR

#1135
US20220193205A1
Human necessities

METHODS OF TREATING CANCER

#1136 ✅ Patent 11,801,285 granted on 2023-10-31
US20220193206A1
Human necessities

Methods and compositions for treating coronavirus infections

#1137
US20220193207A1
Human necessities

COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE

#1138
US20220193208A1
Human necessities

ARGININE DEIMINASE ENCAPSULATED INSIDE ERYTHROCYTES AND THEIR USE IN TREATING CANCER AND ARGINASE-1 DEFICIENCY

#1139
US20220193209A1
Human necessities

COMPOSITIONS AND METHODS FOR REACTIVATING LATENT IMMUNODEFICIENCY VIRUS AND/OR TREATING IMMUNODEFICIENCY VIRUS INFECTION

#1140 ✅ Patent 12,257,294 granted on 2025-03-25
US20220193210A1
Human necessities

Therapeutics for autoimmune disease: synthetic antigens

#1141
US20220193211A1
Human necessities

OVEREXPRESSION OF IMMUNOPROTEASOME IN HOST CELLS FOR GENERATING ANTIGEN-PRESENTING CELLS

#1142
US20220193212A1
Human necessities

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS

#1143
US20220193213A1
Human necessities

HSP70-DERIVED PEPTIDE, PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER USING SAME, IMMUNITY INDUCER, AND METHOD FOR PRODUCING ANTIGEN PRESENTING CELL

#1144 ✅ Patent 11,883,477 granted on 2024-01-30
US20220193214A1
Human necessities

Triple vaccine for diseases caused by and

#1145
US20220193215A1
Human necessities

METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY

#1146 ✅ Patent 11,819,546 granted on 2023-11-21
US20220193216A1
Human necessities

Helicobacter therapeutic

#1147 ✅ Patent 11,766,476 granted on 2023-09-26
US20220193217A1
Human necessities

Genomic deletion in African swine fever vaccine allowing efficient growth in stable cell lines

#1148 ✅ Patent 11,844,831 granted on 2023-12-19
US20220193218A1
Human necessities

African swine fever (ASF) virus vaccines

#1149
US20220193219A1
Human necessities

PROPHYLACTIC TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTION WITH AN ADENOVIRUS BASED VACCINE

#1150
US20220193220A1
Human necessities

IMMUNOGENIC COMPOSITIONS FOR NOVEL REASSORTANT MAMMALIAN ORTHEOVIRUS FROM PIGS

#1151
US20220193221A1
Human necessities

CSFV SUBUNIT VACCINE

#1152
US20220193222A1
Human necessities

VIRAL FORMULATIONS CONTAINING AMINO ACIDS

#1153
US20220193223A1
Human necessities

NUCLEIC ACID VACCINES

#1154
US20220193224A1
Human necessities

RSV-BASED VIRUS-LIKE PARTICLES AND METHODS OF PRODUCTION AND USE THEREOF

#1155
US20220193225A1
Human necessities

COMPOSITIONS AND METHODS FOR SARS-2 VACCINE WITH VIRUS REPLICATIVE PARTICLES AND RECOMBINANT GLYCOPROTEINS

#1156 ✅ Patent 11,471,525 granted on 2022-10-18
US20220193226A1
Human necessities

Coronavirus vaccine

#1157 ✅ Patent 12,296,004 granted on 2025-05-13
US20220193227A1
Human necessities

Recombinant virus with diminished latency and methods of using same

#1158 ✅ Patent 11,759,517 granted on 2023-09-19
US20220193228A1
Human necessities

Pharmaceutical composition that includes the surface and nucleocapsid antigens of the hepatitis B virus

#1159 ✅ Patent 12,263,217 granted on 2025-04-01
US20220193229A1
Human necessities

Nucleic acid stabilizing solution for vaccines, therapy, diagnostics, storage, and transport

#1160
US20220193230A1
Human necessities

COMPOSITIONS, COMPRISING IMPROVED IL-12 GENETIC CONSTRUCTS AND VACCINES, IMMUNOTHERAPEUTICS AND METHODS OF USING THE SAME

#1161
US20220193231A1
Human necessities

PREPARATION OF ZINC ZOLEDRONATE MICRO-NANOPARTICLE ADJUVANT AND USE THEREOF AS VACCINE ADJUVANT

#1162
US20220193232A1
Human necessities

KAPPA MYELOMA ANTIGEN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

#1163
US20220193233A1
Human necessities

STABILIZED ARTIFICIAL IMMUNE COMPLEX ACTIVE IMMUNIZATION STRATEGY THAT SUPPORTS B CELL AND DENDRITIC CELL PROGRAMMING FOR CANCER IMMUNOTHERAPY

#1164
US20220193234A1
Human necessities

METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS

#1165
US20220193235A1
Human necessities

METHODS, SYSTEMS, AND APPARATUS FOR ADMINISTERING A MONOCLONAL AND/OR POLYCLONAL ANTIBODY TREATMENT VIA RAPID INFUSION

#1166 ✅ Patent 11,806,397 granted on 2023-11-07
US20220193236A1
Human necessities

Methods, systems, and apparatus for administering a monoclonal and/or polyclonal antibody treatment via rapid infusion

#1167
US20220193237A1
Human necessities

IPILIMUMAB VARIANTS WITH ENHANCED SPECIFICITY FOR BINDING AT LOW PH

#1168
US20220193238A1
Human necessities

ANTI-IL5R ANTIBODY FORMULATIONS

#1169 ✅ Patent 11,723,878 granted on 2023-08-15
US20220193239A1
Human necessities

Methods for producing fullerene that is bioavailable via inhalation or other absorption modality

#1170
US20220193240A1
Human necessities

TRIGGERABLE HYDROGEL COMPOSITIONS AND RELATED METHODS

#1171
US20220193241A1
Human necessities

AGENT TARGETING DOUBLE-MEMBRANE ORGANELLE DNA

#1172
US20220193242A1
Human necessities

IMMUNOPHILIN-DEPENDENT INHIBITORS AND USES THEREOF

#1173 ✅ Patent 11,925,689 granted on 2024-03-12
US20220193243A1
Human necessities

Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

#1174 ✅ Patent 12,329,822 granted on 2025-06-17
US20220193244A1
Human necessities

ANTIMICROBIAL TAILORED CHITOSAN

#1175 ✅ Patent 11,541,123 granted on 2023-01-03
US20220193245A1
Human necessities

Dual amylin and calcitonin receptor agonists and uses thereof

#1176
US20220193246A1
Human necessities

COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

#1177
US20220193247A1
Human necessities

Novel Codon-Optimized CFTR MRNA

#1178 ✅ Patent 11,571,481 granted on 2023-02-07
US20220193248A1
Human necessities

Peptide-linked drug delivery system

#1179 ✅ Patent 11,865,183 granted on 2024-01-09
US20220193249A1
Human necessities

Conjugates and conjugating reagents comprising a linker that includes at least two (−CH2—CH2—O—) units in a ring

#1180
US20220193250A1
Human necessities

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

#1181
US20220193251A1
Human necessities

CD30 TARGETING ANTIBODY DRUG CONJUGATES AND USES THEREOF

#1182
US20220193252A1
Human necessities

RAAV WITH CHEMICALLY MODIFIED CAPSID

#1183
US20220193253A1
Human necessities

SLOW-RELEASE CYTOKINE CONJUGATES

#1184 ✅ Patent 12,370,265 granted on 2025-07-29
US20220193254A1
Human necessities

HYDROGEL FOR IN-VIVO RELEASE OF MEDICATION

#1185
US20220193255A1
Human necessities

CHLORHEXIDINE SYSTEMS AND METHODS FOR OBTAINING SAME

#1186
US20220193256A1
Human necessities

NANO-ANTIBIOTICS BASED ON SINGLE-CHAIN DEXTRAN NANOPARTICLES

#1187
US20220193257A1
Human necessities

NOOTROPIC FULLERENES AND USE

#1188
US20220193258A1
Human necessities

RECOMBINANT AAV-CRUMBS HOMOLOGUE COMPOSITION AND METHODS FOR TREATING LCA-8 AND PROGRESSIVE RP

#1189
US20220193259A1
Human necessities

GENE THERAPY FOR TREATING OR PREVENTING VISUAL EFFECTS IN BATTEN DISEASE

#1190
US20220193260A1
Human necessities

PROTEINS WITH CARDIOPROTECTIVE ACTIVITY

#1191
US20220193261A1
Human necessities

COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE

#1192
US20220193262A1
Human necessities

HIGH EFFICIENCY GENE DELIVERY SYSTEM

#1193
US20220193263A1
Human necessities

REGULATABLE ADENO-ASSOCIATED VIRUS (AAV) VECTOR

#1194 ✅ Patent 12,357,707 granted on 2025-07-15
US20220193264A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING LAMINOPATHIES

#1195
US20220193265A1
Human necessities

METHODS AND COMPOSITIONS FOR REPROGRAMMING MÜLLER GLIA

#1196
US20220193266A1
Human necessities

A NOVEL CHROMATIN-OPENING ELEMENT FOR STABLE LONG TERM GENE EXPRESSION

#1197
US20220193267A1
Human necessities

ENGINEERED NUCLEASES USEFUL FOR TREATMENT OF HEMOPHILIA A

#1198
US20220193268A1
Human necessities

INTRATHECAL AND INTRAVENOUS COMBINATION GENE THERAPY FOR THE TREATMENT OF INFANTILE BATTEN DISEASE

#1199
US20220193269A1
Human necessities

METHOD OF PREPARING NANOPLATEFORM-BASED DIAGNOSTIC AGENT FOR SELECTIVELY STAINING OF INFLAMMATORY ABNORMAL TISSUE OR TUMOR TISSUE

#1200
US20220193270A1
Human necessities

METHOD FOR ENHANCING TUMOR GROWTH